• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

epilepsy

New imaging framework transforms epilepsy surgery planning

epileptic biomarkers, presurgical evaluation, 12 December 2025/in E-News, Neurology, Surgery /by panglobal

A unified computational framework developed at Carnegie Mellon University enables clinicians to analyse all major epileptic biomarkers within a single system, potentially transforming presurgical evaluation for drug-resistant epilepsy patients. The spatial-temporal-spectral imaging approach achieves localisation accuracy within millimetres of invasive monitoring whilst eliminating the need for separate analysis pipelines.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/12/epilepsy.png 800 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-12-12 08:00:542025-12-09 12:01:59New imaging framework transforms epilepsy surgery planning
blood cells

AI achieves superhuman accuracy in blood cell classification using generative diffusion models

blood, CytoDiffusion, 11 December 2025/in AI, E-News, haematology /by panglobal

Researchers have developed CytoDiffusion, a diffusion-based generative classifier that surpasses clinical experts in blood cell image analysis. The system demonstrates remarkable capabilities in anomaly detection, uncertainty quantification and domain adaptation whilst generating synthetic images indistinguishable from real samples.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/12/blood-cells.png 436 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-12-11 08:30:262025-12-09 11:20:44AI achieves superhuman accuracy in blood cell classification using generative diffusion models
DNA

Psychiatry breakthrough: Genetic mapping reveals five key factors underlying 14 psychiatric disorders

Genetics, psychiatry, 10 December 2025/in E-News, Psychiatry /by panglobal

Researchers have identified five fundamental genetic factors that explain the majority of genetic risk across 14 psychiatric conditions, based on DNA data from over one million people. The findings challenge current diagnostic boundaries and suggest psychiatric disorders arise from shared biological pathways that manifest differently across conditions, potentially informing more targeted therapeutic development.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/12/DNA_9_web-1.jpg 502 600 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-12-10 18:30:182025-12-09 11:53:36Psychiatry breakthrough: Genetic mapping reveals five key factors underlying 14 psychiatric disorders
depressed woman

Violence against women and children emerges as major global health crisis

, 10 December 2025/in E-News, Featured Articles, Mental health /by panglobal

A groundbreaking global study reveals that intimate partner violence and sexual violence against children rank among the top health threats worldwide, contributing to over 50 million disability-adjusted life years annually. The research fundamentally challenges persistent views of these forms of violence as primarily social issues, positioning them instead as critical public health priorities demanding immediate, […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/12/woman-depression.png 800 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-12-10 02:30:322025-12-09 11:30:47Violence against women and children emerges as major global health crisis
MedTech startups

TÜV SÜD releases regulatory roadmap for MedTech start-ups

MedTech, startups, 9 December 2025/in E-News, MedTech /by panglobal

Medical technology start-ups face mounting pressure to navigate complex regulatory frameworks whilst maintaining innovation momentum, according to a newly published white paper from TÜV SÜD. The document, released today, provides structured guidance for young companies seeking to avoid common compliance pitfalls that can delay market entry by months.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/12/MedTech-start-up-generic.png 800 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-12-09 11:10:302025-12-09 11:10:30TÜV SÜD releases regulatory roadmap for MedTech start-ups
stem cells

Landmark stem cell trial: Genetic mismatch no longer a barrier to survival

stem cells, 6 December 2025/in E-News, Genetics /by panglobal

A multicentre trial has demonstrated that patients receiving stem cell transplants from unrelated donors with multiple genetic mismatches can achieve survival rates comparable to those with better-matched donors when using post-transplant cyclophosphamide prophylaxis.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/12/stem_cells.png 436 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-12-06 15:40:162025-12-04 11:25:18Landmark stem cell trial: Genetic mismatch no longer a barrier to survival
gadoquatrane

Paediatric study for Bayer’s investigational MRI contrast agent gadoquatrane in children meets primary and secondary endpoints

Bayer, gadoquatrane, MRI, 5 December 2025/in E-News, Imaging /by panglobal

Bayer has revealed results from the QUANTI Pediatric study, adding to the safety and efficacy data of the investigational low-dose MRI gadolinium-based contrast agent (GBCA) gadoquatrane.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/06/gadoquatrane.jpg 958 1034 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-12-05 09:34:172025-12-05 09:34:17Paediatric study for Bayer’s investigational MRI contrast agent gadoquatrane in children meets primary and secondary endpoints
MRI

Novel manganese-based MOF offers safer alternative to gadolinium MRI contrast

conrast agent, MRI, 5 December 2025/in E-News, Imaging /by panglobal

Researchers at Oregon State University have developed a novel manganese-based contrast agent for magnetic resonance imaging that demonstrates superior performance to current gadolinium-based agents whilst offering improved biocompatibility and reduced environmental concerns. The material, designated BVR-19, represents the first application of metal-organic framework technology incorporating the amino acid L-cystine for medical imaging applications.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/12/MRI_3.png 800 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-12-05 08:00:192025-12-03 14:04:54Novel manganese-based MOF offers safer alternative to gadolinium MRI contrast
Prof. Jeanette Leusen, PhDEd van Rijswijk

Novel first-in-class antibodies block inflammation pathway in autoimmune diseases

antibodies, autoimmune diseases, 4 December 2025/in E-News /by panglobal

Researchers at UMC Utrecht have developed two novel antibodies that specifically target the high-affinity IgG receptor FcγRI, offering a potential therapeutic approach for autoimmune diseases including rheumatoid arthritis, systemic lupus erythematosus, and immune thrombocytopenia. The antibodies, designated C01 and C04, effectively block immune complex binding without triggering receptor activation, addressing a key limitation of previous […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/12/Center-for-Translational-Immunology-Leusen-Group.jpg 467 700 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-12-04 08:00:422025-12-03 13:57:43Novel first-in-class antibodies block inflammation pathway in autoimmune diseases
Schematic illustration of the noninvasive closed-loop spinal interface.© TMIMS

Non-invasive spinal stimulation restores stepping control in paraplegic patients

paraplegia, spinal stimulation, 3 December 2025/in E-News, MedTech, Neurology /by panglobal

Researchers in Japan have developed a breakthrough non-invasive closed-loop spinal stimulation system that enables individuals with paraplegia to regain control of leg stepping movements. The hand-controlled magnetic stimulation technique bypasses spinal cord lesions and strengthens preserved neural circuits, offering a surgical-free alternative for gait rehabilitation after spinal cord injury.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/12/spinal.jpg 844 1474 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-12-03 13:49:412025-12-03 13:49:41Non-invasive spinal stimulation restores stepping control in paraplegic patients
Page 1 of 240123›»

Latest issue of International Hospital

April 2024

12 December 2025

New imaging framework transforms epilepsy surgery planning

11 December 2025

AI achieves superhuman accuracy in blood cell classification using generative diffusion models

11 December 2025

Siemens Healthineers unveils AI-powered imaging chain

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription